Sandoz to acquire Fougera Pharmaceuticals
2 May 2012 | By Novartis
Definitive agreement to acquire Fougera Pharmaceuticals for USD 1.525 billion in an all-cash transaction...
List view / Grid view
News
Novo Nordisk A/S purchases B shares worth DKK 4.2 billion from Novo A/S
2 May 2012 | By Novo Nordisk
Novo Nordisk A/S has entered into an agreement to purchase 5,100,000 B shares...
New product launches on track and revenue continues to show growth, excluding Lexapro (US)
2 May 2012 | By H. Lundbeck A/S
H. Lundbeck A/S reports first quarter revenue of DKK 3,442 million...
Syrris offers global program of free training for chemists
2 May 2012 | By Syrris
Syrris is building on the success of its previous flow chemistry and automated process chemistry seminars...
Oxford BioTherapeutics appoints senior industry leader to head its new clinical development operations
2 May 2012 | By Citigate Dewe Rogerson
Dr Esteban Pombo-Villar appointed as COO of the OBT group...
Recent publicly-funded CATT trial highlights serious safety concerns around unlicensed ocular bevacizumab use versus Lucentis
1 May 2012 | By Novartis
Results from two-year CATT...
GlaxoSmithKline and Yale University establish drug discovery collaboration to design potential new class of medicines
1 May 2012 | By GlaxoSmithKline
GSK and Yale University have established a drug discovery research collaboration...
Biosimilars webinar presented by Catalent expert for the pharmaceutical education and research institute
1 May 2012 | By Catalent Pharma Solutions
Carolyn Finkle at Catalent to present webinar...
Pall expands single-use solutions portfolio with new products at INTERPHEX 2012
1 May 2012 | By Pall Life Sciences
Pall Corporation will introduce five new single-use products at INTERPHEX 2012...
Pfizer and Protalix BioTherapeutics announce FDA approval Of ELELYSO™ (taliglucerase alfa)
1 May 2012 | By Pfizer
The U.S. FDA has approved ELELYSO™...
Gilead initiates Phase 3 clinical trial evaluating GS-1101 for the treatment of chronic lymphocytic leukemia
1 May 2012 | By Gilead Sciences
Gilead Sciences announced that the first patient has been dosed in a Phase 3 clinical trial...
Teva settles Nuvigil litigation with Mylan
30 April 2012 | By Teva Pharmaceutical Industries Ltd
TEVA, has settled patent infringement litigation with Mylan Inc.'s ANDA for Teva’s wakefulness product NUVIGIL® (armodafinil) tablets...
BASF relocates production of Kolliphor TPGS to its Minden site
30 April 2012 | By
BASF will transfer the pharmaceutical production of KolliphorTM TPGS to its Minden facility...
Algeta and Sanofi extend research collaboration evaluating thorium-conjugated tumor-targeting antibody
30 April 2012 | By Citigate Dewe Rogerson
Algeta ASA announces that its research collaboration with Sanofi has been extended...
Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals
29 April 2012 | By Boehringer Ingelheim
New data on TWYNSTA®...
